WO2004035926A1 - Method of manufacturing tissue papers - Google Patents

Method of manufacturing tissue papers Download PDF

Info

Publication number
WO2004035926A1
WO2004035926A1 PCT/KR2002/002228 KR0202228W WO2004035926A1 WO 2004035926 A1 WO2004035926 A1 WO 2004035926A1 KR 0202228 W KR0202228 W KR 0202228W WO 2004035926 A1 WO2004035926 A1 WO 2004035926A1
Authority
WO
WIPO (PCT)
Prior art keywords
mixture
mixing
silver
tissue papers
stirring
Prior art date
Application number
PCT/KR2002/002228
Other languages
French (fr)
Other versions
WO2004035926A8 (en
Inventor
Jung-Hun Choi
Original Assignee
E-Papertec Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E-Papertec Co., Ltd. filed Critical E-Papertec Co., Ltd.
Priority to AU2002368289A priority Critical patent/AU2002368289A1/en
Publication of WO2004035926A1 publication Critical patent/WO2004035926A1/en
Publication of WO2004035926A8 publication Critical patent/WO2004035926A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H5/00Special paper or cardboard not otherwise provided for
    • D21H5/22Fungicidal, bactericidal, insecticidal, disinfecting, antiseptic, or corrosion-inhibiting paper antistatic, antioxygenic paper
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents

Definitions

  • the present invention relates to a method of manufacturing tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications. More particularly, the present invention relates to a method of manufacturing tissue papers containing silver powder which is a natural antifungal and antibacterial substance.
  • Silver which belongs to IB group of the periodic table, has been widely used as a precious metal having a light blue color and beautiful sheen, along with gold. Silver has the highest malleability and ductility next to gold, and can be used in preparing a silver foil of 0.0015 mm in thickness. In addition, 1 g of silver can produce a wire of 1,800 m in length. When being melted, silver occludes a large amount of oxygen from air, while emitting oxygen when being coagulated. Silver is stable in water and air containing oxygen.
  • silver changes into silver peroxide (Ag 2 O 2 ) of black color when reacting with ozone, while changing into silver sulfide (Ag 2 S) of black color when reacting with sulfur or hydrogen sulfide. Also, silver does not react with hydrogen, carbon, carbonic acid, etc., even at high temperature, but is eroded by halogen.
  • Silver is refined from an ore containing silver according to the same process as for refining gold, that is, amalgamation, cyaniding or dry processing, in which the amalgam process is now rarely used.
  • Silver is a good conductor of heat and electricity, and is widely applied as a metal material owing to its mechanical property of good processability.
  • Silver is known to react with toxic materials and thus change its color to blue, and to be beneficial for human health, thereby having been used as a material in manufacturing spoons and chopsticks for a long time. During the settling of the American West, silver was found to prevent milk from going bad.
  • silver is known to benefit the five viscera, namely, liver, lungs, heart, kidneys and spleen, stabilize the mind and a body, and purge noxious vapor and thus lighten the mind and body, resulting in extension of life expectancy, as described in the Chinese herbal medicine guideline "botanical list”. Further, looking at prior research on silver and its uses, a silver solution can completely kill over 650 species of bacteria and even viruses within 6 minutes without harmful side effect.
  • colloidal silver received approval for use as an antibiotic from the American Food and Drug Administration (FDA), and was selected for use in purification systems in a NASA space shuttle of U.S.A., by more than half of airline companies in the world and in the Swiss government. Also, according to a quality test by the certification body Korea Institute of Construction Materials (KICM), a silver synthetic fiber has antifungal effect 90-fold higher than a natural fiber, and has antifungal activity of 96.9 % even after washing.
  • FDA American Food and Drug Administration
  • Korean Pat. Publication No. 2000-250707 registered in Jan. 6, 2000, discloses a method of preparing water- wet tissue papers, in which a water- wet tissue paper is prepared by diluting a colloidal silver solution formed by decomposing pure silver to fine particles under low temperature and low electric current in water filtered through a silver filter, not containing dyes, heavy metals or lime, adding the surfactant sodium isethionate and the flavoring agent ethyl acetoacetate to the colloidal silver dilute, and impregnating the mixture into a water-wet tissue paper.
  • the above method of preparing water- wet tissue papers containing colloidal silver is suitable for manufacturing water-wet tissue papers, but not dried facial tissues or toilet tissues.
  • tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications and thus capable of protecting skin of women and infants, in which silver powder having excellent antibacterial and antifungal activity is applied to the tissue papers.
  • the present invention is directed to a method of manufacturing tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications and thus capable of protecting skin of women and infants, through application of silver powder having excellent antibacterial and antifungal activity to a tissue paper, with which disadvantages encountered in the conventional sanitary and facial tissues can be overcome.
  • silver in a powder form is used.
  • Silver has characters of poor dispersion, insolubility in water and low density. Owing to such characters, silver cannot be easily applied for coating or impregnation.
  • a composition containing silver powder is utilized, in which silver powder is suitably contained in various concentrations of 0.1-1000 ppm depending on intention of use of a tissue paper to which the composition will be applied, taking into consideration desired antibacterial and antifunal activity, perfume, etc.
  • the composition containing silver powder may further comprise a functional drug, an auxiliary drug and an additive at predetermined amounts.
  • Examples of the functional drug may include aldehydes (e.g., phenylacete aldehyde), alcohols (e.g., 2-phenylethanol), isoamyl salicylic acid, geraniol, terbins, and mixtures thereof.
  • Examples of the auxiliary drug may include unsaturated fatty acids, vitamins, minerals, caprylictriglycerin, mimeticon, stearic acid, propylene glycol, benzoic acid, and mixtures thereof.
  • the additive may be selected from the group consisting of dispersing agents, solubilizers (surfactants), and mixtures of thereof.
  • a facially applied sanitary tissue having antifungal activity is prepared as follows.
  • a first mixture is prepared by mixing 1-5 wt% of stearic acid, 5-15 wt% of mineral oil and 3-8 wt% of caprylictriglycerin in a bath with stirring.
  • a second mixture is prepared by mixing with stirring 0.01-0.03 wt% of a functional drug, 0.01-0.03 wt% of propylene glycol, and 0.01-0.02 wt% of benzoic acid in purified water.
  • the first mixture is mixed with the second mixture, in which the ingredients of one of the first and second mixtures are solubilized in the other mixture by being dispersed into a fine state using a surfactant, and silver powder is then added to the resulting composition at various amounts of 0.1-1000 ppm depending on use of tissue papers to which the final composition will be applied. Then, the final composition is applied to a tissue paper web by coating or impregnation.
  • synthetic polymers including polyvinylalcohol, polymetacryl acid, polyethylene imine and polystyrene sulfonic acid, and biological macromolecules, including serum albumin, ⁇ -lactoglobulin, DNA and insulin, are known to be easily solubilized.
  • biological macromolecules including serum albumin, ⁇ -lactoglobulin, DNA and insulin.
  • Valuable vitamins or hormones may be used in the present invention by the conventional techniques in the art, such as solubilization, to give vitamins or hormones a hydrophilic character, or to combine them with a biocide such as phenols to improve effects of the vitamins or hormones, or a method of stimulating emulsion polymerization.
  • the silver powder, the functional drug, the auxiliary drug and the additive may be selected from those commercially available.
  • the prepared composition containing silver powder may be applied to a tissue paper by a mixing method, a surface coating method, a surface absorbing method, or a surface reacting method, thus providing antifugal activity to the tissue paper, and the mixing and coating methods are used together in the present invention.
  • the method of manufacturing tissue papers according to the present invention provides tissue papers having antibacterial and antifungal activity higher than the conventional tissues, and of being nontoxic to the body and maintaining the activity for a long period of time.
  • tissue papers were found to kill all the pathogenic germs cultured on solid culture media.
  • the composition containing silver powder used in preparing the tissue papers can be applied for various products at various amounts, and has excellent antibacterial and antifungal activity and thus effectively protecting skin of women and infants.

Abstract

Disclosed is a method of manufacturing tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications, comprising the steps of: mixing 1-5 wt% of stearic acid, 5-15 wt% of mineral oil and 3-8 wt% of caprylictriglycerin in a bath with stirring to give a first mixture; mixing with stirring 0.01-0.03 wt% of a functional drug, 0.01-0.03 wt% of propylene glycol, 0.01-0.02 wt% of benzoic acid and purified water to give a second mixture; mixing the first mixture with the second mixture, in which the ingredients of the first mixture are solubilized in the second mixture by being dispersed into a fine state using a surfactant; adding silver powder to the resulting composition at various amounts of 0.1-1000 ppm depending on use of tissue papers to which the final composition will be applied; and applying the final composition to a tissue paper web by coating or impregnation.

Description

METHOD OF MANUFACTURING TISSUE PAPERS
TECHNICAL FIELD
The present invention relates to a method of manufacturing tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications. More particularly, the present invention relates to a method of manufacturing tissue papers containing silver powder which is a natural antifungal and antibacterial substance.
PRIOR ART
With the development of industries and human culture, health and pleasant environment are emerging as main interests in the modern society. In particular, to preserve the health of infants, women and the elderly in an unhealthy residential environment, there is a need to remove offensive odor, fungi, bacteria, and the like from the contaminated environment. Harmful fungi and bacteria have been generally inactivated or killed using organic fungicides or bactericides, but the organic compounds are known to be harmful to humans and animals and to pollute the environment. In this regard, nontoxic inorganic compounds are now used instead of the organic compounds, and a variety of efforts have been made to develop colloidal preparations of below 1/1000 of a hair in size.
Silver (Ag), which belongs to IB group of the periodic table, has been widely used as a precious metal having a light blue color and beautiful sheen, along with gold. Silver has the highest malleability and ductility next to gold, and can be used in preparing a silver foil of 0.0015 mm in thickness. In addition, 1 g of silver can produce a wire of 1,800 m in length. When being melted, silver occludes a large amount of oxygen from air, while emitting oxygen when being coagulated. Silver is stable in water and air containing oxygen. However, silver changes into silver peroxide (Ag2O2) of black color when reacting with ozone, while changing into silver sulfide (Ag2S) of black color when reacting with sulfur or hydrogen sulfide. Also, silver does not react with hydrogen, carbon, carbonic acid, etc., even at high temperature, but is eroded by halogen.
Silver is refined from an ore containing silver according to the same process as for refining gold, that is, amalgamation, cyaniding or dry processing, in which the amalgam process is now rarely used. Silver is a good conductor of heat and electricity, and is widely applied as a metal material owing to its mechanical property of good processability. Silver is known to react with toxic materials and thus change its color to blue, and to be beneficial for human health, thereby having been used as a material in manufacturing spoons and chopsticks for a long time. During the settling of the American West, silver was found to prevent milk from going bad. In addition, silver is known to benefit the five viscera, namely, liver, lungs, heart, kidneys and spleen, stabilize the mind and a body, and purge noxious vapor and thus lighten the mind and body, resulting in extension of life expectancy, as described in the Chinese herbal medicine guideline "botanical list". Further, looking at prior research on silver and its uses, a silver solution can completely kill over 650 species of bacteria and even viruses within 6 minutes without harmful side effect. Because of being proven to have excellent effect in killing bacteria and fungi and thus inhibiting the growth of germs harmful for the body, colloidal silver received approval for use as an antibiotic from the American Food and Drug Administration (FDA), and was selected for use in purification systems in a NASA space shuttle of U.S.A., by more than half of airline companies in the world and in the Swiss government. Also, according to a quality test by the certification body Korea Institute of Construction Materials (KICM), a silver synthetic fiber has antifungal effect 90-fold higher than a natural fiber, and has antifungal activity of 96.9 % even after washing.
Korean Pat. Publication No. 2000-250707, registered in Jan. 6, 2000, discloses a method of preparing water- wet tissue papers, in which a water- wet tissue paper is prepared by diluting a colloidal silver solution formed by decomposing pure silver to fine particles under low temperature and low electric current in water filtered through a silver filter, not containing dyes, heavy metals or lime, adding the surfactant sodium isethionate and the flavoring agent ethyl acetoacetate to the colloidal silver dilute, and impregnating the mixture into a water-wet tissue paper.
The above method of preparing water- wet tissue papers containing colloidal silver is suitable for manufacturing water-wet tissue papers, but not dried facial tissues or toilet tissues.
DISCLOSURE OF THE INVENTION
Therefore, it is an object of the present invention to provide a method of manufacturing tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications and thus capable of protecting skin of women and infants, in which silver powder having excellent antibacterial and antifungal activity is applied to the tissue papers.
BEST MODES FOR CARRYING OUT THE INVENTION
The present invention is directed to a method of manufacturing tissue papers having antifungal and antibacterial activity for sanitary wipes and facial applications and thus capable of protecting skin of women and infants, through application of silver powder having excellent antibacterial and antifungal activity to a tissue paper, with which disadvantages encountered in the conventional sanitary and facial tissues can be overcome. In accordance with the present invention, silver in a powder form is used.
Silver has characters of poor dispersion, insolubility in water and low density. Owing to such characters, silver cannot be easily applied for coating or impregnation. To resolve the problem, in accordance with the present invention, a composition containing silver powder is utilized, in which silver powder is suitably contained in various concentrations of 0.1-1000 ppm depending on intention of use of a tissue paper to which the composition will be applied, taking into consideration desired antibacterial and antifunal activity, perfume, etc.
According to use of the tissue paper, if desired, the composition containing silver powder may further comprise a functional drug, an auxiliary drug and an additive at predetermined amounts.
Examples of the functional drug may include aldehydes (e.g., phenylacete aldehyde), alcohols (e.g., 2-phenylethanol), isoamyl salicylic acid, geraniol, terbins, and mixtures thereof. Examples of the auxiliary drug may include unsaturated fatty acids, vitamins, minerals, caprylictriglycerin, mimeticon, stearic acid, propylene glycol, benzoic acid, and mixtures thereof.
The additive may be selected from the group consisting of dispersing agents, solubilizers (surfactants), and mixtures of thereof. In detail, in a preferred embodiment of the present invention, a facially applied sanitary tissue having antifungal activity is prepared as follows.
A first mixture is prepared by mixing 1-5 wt% of stearic acid, 5-15 wt% of mineral oil and 3-8 wt% of caprylictriglycerin in a bath with stirring. Separately, a second mixture is prepared by mixing with stirring 0.01-0.03 wt% of a functional drug, 0.01-0.03 wt% of propylene glycol, and 0.01-0.02 wt% of benzoic acid in purified water. The first mixture is mixed with the second mixture, in which the ingredients of one of the first and second mixtures are solubilized in the other mixture by being dispersed into a fine state using a surfactant, and silver powder is then added to the resulting composition at various amounts of 0.1-1000 ppm depending on use of tissue papers to which the final composition will be applied. Then, the final composition is applied to a tissue paper web by coating or impregnation.
Through the above solubilization, synthetic polymers, including polyvinylalcohol, polymetacryl acid, polyethylene imine and polystyrene sulfonic acid, and biological macromolecules, including serum albumin, β-lactoglobulin, DNA and insulin, are known to be easily solubilized. The phenomena of increasing solubility of poorly water-soluble materials using a large amount of aromatic sulfonic acid, aromatic carboxic acid, phenols, alcohols, pyrolidones or urea is called hydrotropy. Valuable vitamins or hormones may be used in the present invention by the conventional techniques in the art, such as solubilization, to give vitamins or hormones a hydrophilic character, or to combine them with a biocide such as phenols to improve effects of the vitamins or hormones, or a method of stimulating emulsion polymerization. In addition, the silver powder, the functional drug, the auxiliary drug and the additive may be selected from those commercially available. The prepared composition containing silver powder may be applied to a tissue paper by a mixing method, a surface coating method, a surface absorbing method, or a surface reacting method, thus providing antifugal activity to the tissue paper, and the mixing and coating methods are used together in the present invention.
INDUSTRIAL APPLICABILITY
As described hereinbefore, the method of manufacturing tissue papers according to the present invention provides tissue papers having antibacterial and antifungal activity higher than the conventional tissues, and of being nontoxic to the body and maintaining the activity for a long period of time. Through a testing for antibacterial and antifungal activity of the tissue papers against various pathogenic germs, the tissue papers were found to kill all the pathogenic germs cultured on solid culture media. In addition, the composition containing silver powder used in preparing the tissue papers can be applied for various products at various amounts, and has excellent antibacterial and antifungal activity and thus effectively protecting skin of women and infants.

Claims

1. A method of manufacturing tissue papers, comprising the steps of: mixing 1-5 wt% of stearic acid, 5-15 wt% of mineral oil and 3-8 wt% of caprylictriglycerin in a bath with stirring to give a first mixture; mixing with stirring 0.01-0.03 wt% of a functional drug, 0.01-0.03 wt% of propylene glycol, 0.01-0.02 wt% of benzoic acid and purified water to give a second mixture; mixing the first mixture with the second mixture, in which the ingredients of one of the first and second mixtures are solubilized in the other mixture by being dispersed into a fine state using a surfactant; adding silver powder to the resulting composition at various amounts of 0.1-1000 ppm depending on use of tissue papers to which the final composition will be applied; and applying the final composition to a tissue paper web by coating or impregnation.
PCT/KR2002/002228 2002-10-16 2002-11-28 Method of manufacturing tissue papers WO2004035926A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002368289A AU2002368289A1 (en) 2002-10-16 2002-11-28 Method of manufacturing tissue papers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020063138A KR20040033855A (en) 2002-10-16 2002-10-16 Method of manufacturing a tissue
KR10-2002-0063138 2002-10-16

Publications (2)

Publication Number Publication Date
WO2004035926A1 true WO2004035926A1 (en) 2004-04-29
WO2004035926A8 WO2004035926A8 (en) 2005-03-24

Family

ID=32105589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2002/002228 WO2004035926A1 (en) 2002-10-16 2002-11-28 Method of manufacturing tissue papers

Country Status (3)

Country Link
KR (1) KR20040033855A (en)
AU (1) AU2002368289A1 (en)
WO (1) WO2004035926A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006040570A1 (en) * 2004-10-16 2006-04-20 Paul George Welfle Exfoliant composition and kit comprising a pad coated with metal particles
RU2651249C1 (en) * 2016-11-10 2018-04-18 Общество с ограниченной ответственностью "Бумага и Картон" (ООО "Бумага и Картон") Method of producing paper with antimicrobial characteristics

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101104600B1 (en) * 2009-10-28 2012-01-12 고석우 Painless private blood vessels with private blood vessel protection caps
KR101860485B1 (en) 2011-11-03 2018-07-02 (주)아모레퍼시픽 Tissue for skin with nano-emulsion, method for manufacturing the same and method for using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03898A (en) * 1990-01-03 1991-01-07 Kenji Ichikawa Paper having antimicrobial property
JPH0776503A (en) * 1993-09-06 1995-03-20 Nikko:Kk Antimicrobial liquid material, antimicrobial coating agent, antimicrobial spraying agent, antimicrobial coating agent and antimicrobial paper
JPH08325103A (en) * 1995-05-26 1996-12-10 New Oji Paper Co Ltd Antimicrobial paper
KR0174305B1 (en) * 1994-11-07 1999-03-20 안드레아스 바우만; 놀트홀름 베렌스 Aqueous silver composition
US6197315B1 (en) * 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2870694B2 (en) * 1988-10-11 1999-03-17 日本製箔株式会社 Antibacterial paper
US5830487A (en) * 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
JPH07204148A (en) * 1994-01-21 1995-08-08 New Oji Paper Co Ltd Antimicrobial wiping paper
KR100201536B1 (en) * 1997-05-23 1999-06-15 손성수 Manufacturing method for tissue having propolis
KR100250707B1 (en) * 1998-02-16 2000-04-01 강남석 Method for making water tissue
KR20010044617A (en) * 2001-03-12 2001-06-05 김수일 Manufacturing method of sterilization drug and packing paper of food therefor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03898A (en) * 1990-01-03 1991-01-07 Kenji Ichikawa Paper having antimicrobial property
JPH0776503A (en) * 1993-09-06 1995-03-20 Nikko:Kk Antimicrobial liquid material, antimicrobial coating agent, antimicrobial spraying agent, antimicrobial coating agent and antimicrobial paper
KR0174305B1 (en) * 1994-11-07 1999-03-20 안드레아스 바우만; 놀트홀름 베렌스 Aqueous silver composition
JPH08325103A (en) * 1995-05-26 1996-12-10 New Oji Paper Co Ltd Antimicrobial paper
US6197315B1 (en) * 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006040570A1 (en) * 2004-10-16 2006-04-20 Paul George Welfle Exfoliant composition and kit comprising a pad coated with metal particles
RU2651249C1 (en) * 2016-11-10 2018-04-18 Общество с ограниченной ответственностью "Бумага и Картон" (ООО "Бумага и Картон") Method of producing paper with antimicrobial characteristics

Also Published As

Publication number Publication date
WO2004035926A8 (en) 2005-03-24
AU2002368289A1 (en) 2004-05-04
KR20040033855A (en) 2004-04-28

Similar Documents

Publication Publication Date Title
WO2022032440A1 (en) Composite microsphere, and preparation method therefor and application thereof
CN108553366A (en) A kind of antibacterial wet tissue
CN111802404A (en) Nano silver composite antibacterial and sterilizing material
JP2009221177A (en) Antibacterial-and-antifungal composition and applied goods thereof
JP4926448B2 (en) Anti-aging agent
WO2004035926A1 (en) Method of manufacturing tissue papers
JP4939782B2 (en) Antibacterial cosmetics
CN114870056A (en) Antibacterial deodorant and preparation method thereof
JPH06321714A (en) Preservative or medicated bath
JP3130775B2 (en) Ultrafine antibacterial ceramic powder
CN113303330A (en) Composite disinfectant and preparation process thereof
EP1512409B1 (en) Composition against infestment of lice
JP3723892B2 (en) Reduced antioxidant and method for producing the same
KR100218093B1 (en) Germicide composition from yucca extract for animal
KR100250707B1 (en) Method for making water tissue
KR960004496B1 (en) Making-up soap composition containing onion garlic
KR20090099113A (en) Method for producing of tissue
JP3611204B2 (en) Garlic extract-containing food with reduced garlic odor
KR20030042191A (en) Silver-containing body cleanser composition and preparation method thereof
EP3993627A1 (en) Ready-for-use disinfectant
KR20070119972A (en) Method for producing of tissue
JP4713093B2 (en) Functional water
JP2006169222A (en) Antibacterial composition
CN111000764A (en) Antibacterial skin cleaning product
TW487761B (en) A long-acting disinfectant and its preparation method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 18/2004 ADD "DECLARATION UNDER RULE 4.17: - AS TO THE IDENTITY OF THE INVENTOR (RULE4.17(I)) FOR ALL DESIGNATIONS."; ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV)) FOR US ONLY."

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP